Analyst Ratings for Bristol-Myers Squibb Co. (BMY) [Buys]
BMY Rating Summary
BMY Price Target Summary
- Highest: $90.00 (Citi)
- Lowest: $40.00 (Morgan Stanley)
- Average: $59.27
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$59.27 (+32.6%)
* Over Last 12-Mos
Rating Score: 1.7 / 10
Percentile Rank: 12%
Rating Score: 1.7 / 10
Percentile Rank: 12%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/17/2021 | Goldman Sachs » Updated 12/12/2023 |
Chris Shibutani | New Coverage | Buy (N/A) |
60.00 (69.00) |
62.17 (44.70) |
-28.1% | Details |
| 7/26/2021 | Truist Securities » Updated 4/25/2024 |
Robyn Karnauskas | New Coverage | Buy (N/A) |
64.00 (68.00) |
68.34 (44.70) |
-34.59% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
